This site is intended for health professionals only

NSAIDs in early pregnancy double risk of miscarriage

The risk of miscarriage is more than doubled in women who take any dose of non-aspirin NSAIDs in early pregnancy compared with women who do not take the drugs, a study has found.

Of 4,705 cases of miscarriages recorded in the Quebec Pregnancy Registry before the 20th week of gestation, 7.5% had used non-aspirin NSAIDs, identified by records of filled prescriptions. Of the 47,050 women in the control group who did not miscarry, 2.6% had taken nonaspirin NSAIDs.

After adjusting the results for confounding variables, the use of non-aspirin NSAIDs during pregnancy was significantly associated with a 2.4-fold dose-independent increased risk of miscarriage.

The highest risk was in patients who used diclofenac alone – who had more than a three-fold risk, while the lowest risk was in those who took rofecoxib alone – who had an 80% higher risk.

Study leader Dr Hamid Reza Nakhai-Pour, clinical epidemiologist at the University of Montreal, concluded: ‘Our results suggest a class effect on the risk of clinically detected spontaneous abortion. Non-aspirin NSAIDs should be used with caution during pregnancy', he added.

CMAJ 2011, online 6 September


Visit Pulse Reference for details on 140 symptoms, including easily searchable symptoms and categories, offering you a free platform to check symptoms and receive potential diagnoses during consultations.